This new understanding led to a revolution in practice. The English surgeon Joseph Lister, grasping the implications of Pasteur’s work, introduced antiseptic surgery by spraying carbolic acid on wounds, instruments, and even in the air of the operating theater. The results were staggering: mortality from surgery plummeted. The operating room, once a bloody theater of inevitable sepsis, began its long journey toward becoming the sterile, controlled environment we know today. Aseptic technique—the practice of keeping things sterile, rather than killing germs after they arrived—soon followed. Simultaneously, the germ theory gave birth to the fields of bacteriology and immunology. It spurred the search for “magic bullets”—chemicals that would kill the invading microbe without harming the patient.
This quest was dramatically realized by Paul Ehrlich, who, after hundreds of failed experiments, developed Salvarsan 606, an effective treatment for syphilis. Although it was an arsenic-based compound with significant toxicity, it was the first synthetic drug developed to treat an infectious disease, opening the door for the field of chemotherapy. The principles of public health were also revolutionized. The understanding that diseases like cholera were waterborne, as famously demonstrated by John Snow during the 1854 Broad Street cholera outbreak in London, led to massive investments in clean water and 女性衛生用品 systems, which have arguably saved more lives than any other medical intervention in history.
The 20th century witnessed an explosion of medical innovation that would have been unimaginable to a physician from the preceding century, building directly upon the foundation laid by Pasteur, Koch, and Lister. Perhaps the most dramatic chapter in this story is the discovery of antibiotics. In 1928, Alexander Fleming’s serendipitous observation of a mold (Penicillium notatum) inhibiting bacterial growth on a petri dish languished for a decade until it was developed into a usable drug by Howard Florey and Ernst Boris Chain. Penicillin, mass-produced in time for World War II, was a genuine miracle. It transformed bacterial pneumonia from a frequently fatal illness into a curable one, made syphilis a treatable infection, and dramatically reduced the threat of wound infections. The subsequent development of a whole arsenal of antibiotics gave physicians, for the first time in history, the power to reliably cure the most common and deadly forms of infectious disease. The war on infectious disease seemed to be on the verge of being won.
But the narrative of modern healthcare is not a simple tale of triumphant progress. It is a complex story of constant adaptation and unforeseen consequences. Just as we were taming acute infectious diseases, a new set of health challenges emerged as the primary burden of illness in the developed world. With people living longer thanks to antibiotics, sanitation, and better nutrition, chronic, non-communicable diseases like heart disease, cancer, stroke, and diabetes moved to the forefront. These were not diseases with a single, clear-cut cause like a bacterium, but complex, multifactorial conditions arising from a combination of genetics, lifestyle, and environment. This demanded a new approach to medicine.